EASTERN ANALYTICAL SYMPOSIUM & EXPOSITION 2024 Final Program

Summary of the 2024 Eastern Analytical Symposium & Exposition (EAS) — Final Program

Significance of the Topic

The 2024 Eastern Analytical Symposium & Exposition (EAS) is a multidisciplinary meeting focused on modern analytical science applied to real-world problems. The program emphasizes cross-technology integration — chromatography, mass spectrometry, spectroscopy, nuclear magnetic resonance, microscopy, and data science — to address high-priority issues such as PFAS monitoring, nitrosamine control, biopharmaceutical characterization (including oligonucleotides, peptides, proteins, and vaccines), forensic analysis, sustainability, and regulatory alignment (e.g., ICH Q14, USP expectations). The symposium provides a platform for method development, validation, automation and high-throughput workflows, and for translating novel instrumentation and chemometric/AI approaches into operational laboratory practice.

Objectives and Overview of the Program

• Showcase technical advances across the analytical spectrum through technical sessions, short courses, workshops, posters, exhibitions and demonstrations.
• Promote problem-solving via cross-disciplinary dialogue and industry–academic exchange under the theme Partners in Problem Solving.
• Highlight regulatory and quality topics (keynote on quality in low- and middle-income countries; sessions on ICH Q14/analytical lifecycle management and USP guidance implementation).
• Recognize scientific contributions via EAS awards in separation science, mass spectrometry, vibrational spectroscopy, magnetic resonance, and analytical chemistry.

Methodology and Program Structure

The meeting combined multiple educational formats to cover both fundamentals and cutting-edge research:

• Full-day short courses (HPLC/UHPLC fundamentals and troubleshooting, NMR, Oligonucleotide chromatography, SFC, PFAS, PFAS analytical approaches, LC-MS/MS method validation, HPTLC, O-PTIR/IR/Raman interpretation, and data analytics for analytical chemists).
• Technical program with concurrent sessions organized into “mini-conferences” (environmental & food analysis; forensic analysis; AI/ML & chemical data science; laboratory management; bioanalysis; mass spectrometry; chromatography; spectroscopy; pharmaceutical analysis; separations and modeling; high-throughput experimentation; and nanotechnology applications).
• E-posters with dedicated student award sessions, vendor exposition with demo rooms and hands-on demonstrations, career development workshops (speed mentoring, employment bureau) and public-facing seminars for students.

Used Instrumentation

The program covered a broad range of instrumentation and platform-level workflows. Representative instrument categories, platforms and vendors emphasized in sessions, demonstrations and exhibitor listings included:

• Liquid chromatography and UHPLC/HPLC systems and columns (Waters Alliance, UPLC, Evosphere, monodisperse fully porous particle columns, SPP and MFPP technologies; HILIC, reversed-phase and normal phase modes).
• Mass spectrometry: LC-MS/MS (quantitative bioanalysis), QToF, high-throughput MS (acoustic ejection MS, droplet-APCI-MS, FIA-MS), ambient MS, MALDI imaging, GC-MS/MS, GC-VUV, sp-ICP-MS and charge-detection MS for megadalton particles; vendors: Waters, Sciex, Agilent, Thermo Fisher, JEOL, LECO, PerkinElmer, GERSTEL.
• Spectroscopy and imaging: FTIR, Raman (including handheld Raman), deep UV resonance Raman, O-PTIR/sub-micron IR, hyperspectral imaging, NIR, tip-enhanced Raman (TERS), TOF-SIMS, photothermal IR and photothermal spectroscopy platforms; vendors: Bruker, Photothermal Spectroscopy Corp., Lazar Scientific, BrightSpec.
• Nuclear magnetic resonance (qNMR, heteronuclear experiments, specialized probes, MAS and SAS instrumentation) and cryo-electron microscopy for nanoparticle characterization.
• Chromatography detectors/auxiliary instrumentation: MALS (DAWN), charged aerosol detection (CAD), headspace sampling, static/dynamic headspace, polymer and protein characterization tools (light scattering, DLS), SPE automation and microsampling tools (VAMS).
• Sample preparation and high-throughput automation: automated workstations for biorelevant solubility, automated LC method development, robotic sample processors, plate-based SPE, microreactors and automated screening workstations.
• Field and portable analysis: handheld Raman, field-deployable kits and FDA satellite laboratory toolkits for remote and mail-facility screening.

Key Themes, Highlights and Main Messages

• Regulatory and Quality: Substantial attention to regulatory harmonization and analytic life-cycle management. Sessions on implementing ICH Q14, USP guidance, and analytical target profiles emphasized robust method development, risk-based validation and documentation aligned with regulatory expectations.
• PFAS and Environmental Analytics: Multiple sessions on PFAS detection (targeted and non-targeted approaches), combustion ion chromatography, SERS and LC-MS methods, and the challenge of “missing fluorine” in complex mixtures. Emphasis on sensitive extraction/clean-up for difficult matrices (food, packaging, biological tissues).
• Nitrosamines and Impurities: Focused talks on nitrosamine formation mechanisms (role of NOx/nitrites), analytical LC-MS approaches for NDSRIs, method robustness and establishing acceptable intakes.
• Oligonucleotide and Biotherapeutic Analysis: Dedicated tracks on chromatographic and MS strategies for oligonucleotides, method validation, assay sensitivity, extraction and mitigation of matrix and non-specific binding, and multi-dimensional separations for vaccine components.
• Advances in Mass Spectrometry and High-Throughput Screening: Presentations on acoustic ejection MS, ambient MS automation, ultrahigh-throughput platforms and applications to early-stage drug discovery and immunopeptidomics.
• Spectroscopy and Imaging Innovations: New capabilities in sub-micron IR (O-PTIR), deep UV resonance Raman for mRNA stability assessment, MALDI imaging for spatial metabolomics, and hyperspectral methods for biomedical and materials applications.
• Data Science and Machine Learning: Growth of AI/ML applications in method development, retention prediction, chromatographic modeling (DryLab/Fusion QbD-like approaches), spectral classification, and chemometrics for hyphenated data deconvolution.
• Sustainability and Greener Analytical Strategies: Emphasis on greener separations (SFC), reduced solvent consumption, sustainable lab practices, and method modernization to improve safety and environmental footprint.
• Forensic and Field Analysis: Demonstrated advances in forensic microscopy, portable spectroscopy, PCRS for soil, rapid field deployable screening, and high-resolution ion mobility for trace PFAS fingerprinting.
• Awards and Recognition: Keynote from USP leadership on quality in low- and middle-income countries; award lectures from leading scientists on vibrational spectroscopy, mass spectrometry, magnetic resonance, separation science and analytical chemistry illustrating the intersection of fundamental advances with practical applications.

Benefits and Practical Applications

• Laboratories can directly translate presented workflows to improve sensitivity and robustness: e.g., adopt MFPP/SPP column technologies, CAD and MALS detector strategies, or optimized LC-MS/MS approaches for trace impurities and oligonucleotide assays.
• Automation and high-throughput platforms reduce cycle time for method development and screening, enabling faster decision-making in discovery and early development.
• AI/ML and predictive retention modeling can lower experimental burden, accelerate method development and increase reproducibility when integrated with chromatography data systems.
• New spectroscopy modalities (deep UV Raman, O-PTIR) and imaging tools provide orthogonal, spatially resolved characterization for complex biotherapeutic formulations, vaccine components, and materials science problems.
• Regulatory-focused content supports implementation of robust analytical lifecycle management in regulated environments, facilitating compliance with ICH and USP expectations.
• Field-deployable methods and satellite lab workflows strengthen rapid response capabilities for public-health, regulatory, and forensic operations.

Future Trends and Applications

• Broader adoption of integrated digital workflows that combine instrument automation, chromatographic/predictive modeling, and AI-driven analysis for method design and transfer.
• Expansion of high-throughput mass spectrometry techniques into routine ADME/tox screening and early-phase candidate triage.
• Continued growth of spectroscopic micro-imaging (O-PTIR, sub-micron IR, deep UV Raman) for nanoparticle, vaccine and biological matrix characterization with increasing adoption in QC environments.
• Increased emphasis on sustainability in method selection (SFC, greener solvents) and on reducing laboratory energy/solvent footprints via process redesign.
• Stronger coupling of non-targeted analyses, combustion techniques and total fluorine approaches to close analytical gaps in PFAS speciation and mass balance studies.
• Greater regulatory reliance on validated, model-informed analytical workflows (MODR) and digital records to speed review and lifecycle updates.
• Democratization of instrumentation development (e.g., 3D-printed components for NMR probes) and open-source software/tools for method development, making advanced analytical capabilities more accessible.

Conclusion

The 2024 EAS Final Program presented a comprehensive survey of contemporary analytical chemistry challenges and solutions. Emphasizing cross-disciplinary collaboration, the meeting highlighted innovations in instrumentation, data science, automation and regulatory practice. For analytical scientists, the practical outcomes include new method strategies for PFAS, nitrosamines, biologics and oligonucleotides; guidance on lifecycle and quality approaches aligned to ICH/USP; and actionable pathways to adopt high-throughput and greener technologies in routine workflows.

Reference

• Eastern Analytical Symposium & Exposition. Final Program. Crowne Plaza Princeton Conference Center; November 18–20, 2024.